ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
15 Mar 2024

VD köper aktier i Acarix

New York, New York, 15 mars 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar att Aamir Ma...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
06 Mar 2024

Idag inleds utnyttjandeperioden för Acarix teckningsoptioner av serie 2024:U1 (TO2)

Utnyttjandeperioden för de teckningsoptioner av serie 2024:U1 (TO2) (”Teckningsoptioner”) som emitterades i samband me...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
06 Mar 2024

The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today

The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acarix" or the "Com...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
15 Feb 2024

Acarix strengthens US Advisory Board with three industry leaders

New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
15 Feb 2024

Acarix expanderar USA-baserat Advisory Board med tre nya rådgivare

New York, New York, 15 februari 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, har utnämnt ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
14 Feb 2024

Invitation to presentation of Acarix´s fourth quarter report

Acarix will publish its fourth quarter results on Thursday 15 February 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (C...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
14 Feb 2024

Inbjudan till presentation av Acarix delårsrapport för fjärde kvartalet 2023

Acarix publicerar sin rapport för fjärde kvartalet på torsdag den 15 februari 2024 kl 08.00. En direktsänd webbs&a...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
02 Feb 2024

Acarix CADScor System now listed on US Federal Supply Schedule

Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
02 Feb 2024

Acarix CADScor System är nu listat på US Federal Supply Schedule

Acarix, ledande inom avancerad akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag att CADScor System har adderats till d...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
01 Feb 2024

Acarix appoints Aamir Mahmood as new CEO

Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
01 Feb 2024

Acarix utser Aamir Mahmood till ny VD

Stockholm, Sverige, 1 februari 2024 - Styrelsen för Acarix AB tillkännager idag att Aamir Mahmood utsetts till ny VD och till...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
13 Dec 2023

Acarix strengthens US sales leadership team

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces a new US sales structure that aims to further strengthen its...
Continue reading
  • «
  • ‹
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.